Biotin compounds for targetting tumors and sites of infection
Patent
·
OSTI ID:871360
- Boston, MA
- De Catur, GA
- North Scituate, MA
Novel biotin amide analogs that are useful for targeting therapeutic and imaging agents to sites of infection and tumors in vivo are disclosed.
- Research Organization:
- Massachusetts Inst. of Technology (MIT), Cambridge, MA (United States)
- DOE Contract Number:
- FG02-86ER60460
- Assignee:
- JMDE Trust (Newton, MA)
- Patent Number(s):
- US 5716594
- OSTI ID:
- 871360
- Country of Publication:
- United States
- Language:
- English
Avidin binding of radiolabeled biotin derivatives.
|
journal | January 1988 |
An approach to the targeted attachment of peptides and proteins to solid supports.
|
journal | October 1976 |
99mTc Labeled Biotin Conjugate in a Tumor“Pretargeting” Approach with Monoclonal Antibodies
|
journal | November 1992 |
Similar Records
Biotin compounds for targeting tumors and sites of infection
Synthesis of fluorine-18-labeled biotin derivatives: Biodistribution and infection localization
Design and synthesis of metabolically stable chelate-biotin conjugates for pretargeted tumor radioimmunotherapy
Patent
·
Tue Feb 10 00:00:00 EST 1998
·
OSTI ID:871360
+1 more
Synthesis of fluorine-18-labeled biotin derivatives: Biodistribution and infection localization
Journal Article
·
Sat Oct 01 00:00:00 EDT 1994
· Journal of Nuclear Medicine
·
OSTI ID:871360
Design and synthesis of metabolically stable chelate-biotin conjugates for pretargeted tumor radioimmunotherapy
Conference
·
Fri Dec 01 00:00:00 EST 1995
·
OSTI ID:871360